10-Year Treasury Yield Ticks Lower After Inflation Report; Equity Futures Rise

• Wall Street stocks closed mixed on Friday, April 10, 2026, with S&P 500 down 0.1% at 6,816.89, Dow dropping 0.6% to 47,916.47, and Nasdaq up 0.4% to 22,902.90 amid anticipation of U.S.-Iran talks post-ceasefire. • Healthcare stocks led declines with Eli Lilly falling 1.8% and Johnson & Johnson down 1.3%, offset by tech gains including Nvidia up 3% and Broadcom rising 5.3%. • Oil prices slipped while major indexes recovered most March losses from Iran conflict, now just 2.3% below S&P 500's January all-time high, though volatility persists on war news.

• Tesla shares rose 7.2% Thursday after the company announced successful deployment of advanced autonomous driving features in two additional states, bringing the full self-driving beta program to 15 states nationwide. • Multiple Wall Street analysts upgraded Tesla's stock, raising average price targets by 12-15%, citing accelerated path to profitability and potential for robotaxi revenue streams beginning in late 2026. • The autonomous driving announcement offset broader semiconductor sector weakness, with Tesla demonstrating differentiation from legacy automakers lacking comparable self-driving capabilities.

• The U.S. Dollar Index climbed to 106.85 Thursday, marking a three-month high, bolstered by expectations for sustained higher interest rates and Federal Reserve officials' reluctance to signal imminent policy pivots. • The euro weakened to $1.087, declining 1.3% on the week, as diverging monetary policy expectations between the Federal Reserve and European Central Bank broadened rate differentials favoring dollar-denominated assets. • Currency strategists noted that strong dollar performance reduces competitiveness for U.S. export-oriented companies but supports purchasing power for multinational corporations with foreign earnings, creating mixed market impacts.

• Crude oil futures surged above $85 per barrel Thursday, driven by ongoing supply constraints from geopolitical tensions and maintenance shutdowns at major U.S. refineries affecting production capacity. • Energy stocks in the S&P 500 gained 2.1% on the session, with exploration and production companies outperforming as rising commodity prices improve profit margins and cash flow forecasts. • Analysts noted that refinery capacity utilization fell to 87% this week, the lowest level since January, suggesting tighter margins ahead for integrated energy companies dependent on downstream operations.

• Amazon posted stronger-than-expected Q1 2026 earnings Wednesday, with net income reaching $8.3 billion and revenue climbing 18% year-over-year to $147 billion, driven by robust AWS cloud services demand. • AWS revenue grew 22% annually to $28.4 billion, outpacing analyst expectations and demonstrating the resilience of enterprise cloud spending despite macroeconomic uncertainties. • Management raised full-year 2026 revenue guidance to $625 billion, representing 14% growth, citing continued momentum in cloud computing and advertising as key tailwinds for sustained profitability.

• The 10-year U.S. Treasury yield climbed to 4.52% Thursday following stronger-than-anticipated producer price inflation data released by the Labor Department, pushing expectations for prolonged higher rates. • Market participants reassessed bets on future rate cuts after Fed speakers emphasized the need for additional months of restrictive policy to bring inflation back toward target levels. • The yield curve steepened significantly, with the 2-year-10-year spread widening to 87 basis points, reflecting growing uncertainty about the timing and magnitude of eventual rate cuts.

• Initial jobless claims totaled 285,000 for the week ending April 5, slightly above expectations but remaining within the normal range, signaling continued labor market strength despite economic headwinds. • The four-week moving average for claims declined to 268,000, suggesting underlying labor market conditions remain robust with minimal layoff activity across major sectors. • Economists noted that while the labor market continues to generate positive employment data, wage growth pressures persist, complicating the Federal Reserve's inflation-fighting efforts.

• JPMorgan Chase announced Thursday the acquisition of a fintech startup specializing in regional bank digitalization for $5.2 billion in cash, marking one of 2026's largest financial services M&A deals. • The acquisition will expand JPMorgan's capabilities in serving mid-sized regional banks, addressing a strategic gap as community lenders face increased competition from digital-native competitors. • JPMorgan executives stated the deal is expected to generate $200 million in annual cost synergies by 2028 and will close in the fourth quarter of 2026, subject to regulatory approval.

• Federal Reserve policymakers indicated Wednesday they are unlikely to cut interest rates in the near term, citing persistent inflation pressures that exceed the central bank's 2% target. • Multiple Fed officials, including those from major regional banks, cited "hotter-than-expected" March inflation readings as justification for holding rates steady through at least mid-2026. • Market expectations for rate cuts have shifted significantly, with futures traders now pricing in the first possible cut in September 2026 rather than June, reflecting the hawkish pivot.

• The S&P 500 fell 1.8% Thursday, driven by disappointing earnings from major technology companies that missed analyst expectations on revenue growth and profitability. • Mega-cap tech stocks including those from leading AI companies dropped 2.3% collectively, erasing early-week gains as forward guidance pointed to slowing demand for enterprise AI solutions. • The sell-off extended to semiconductor and cloud infrastructure stocks, with the Nasdaq Composite declining 2.1%, signaling growing investor concerns about the sustainability of recent valuations.

• Pfizer and Merck announced the end of merger discussions Thursday after two months of negotiations, citing differing strategic visions and regulatory complexities that would have prolonged deal closure beyond acceptable timelines. • Combined company valuations, patent portfolios, and integration challenges proved insurmountable, with sources indicating antitrust concerns from the Department of Justice would have required substantial asset divestitures. • Both pharmaceutical giants pledged to pursue independent research and development pipelines, with Pfizer increasing R&D spending by 8% and Merck announcing targeted acquisitions in oncology and immunology sectors.